Ergoteles LLC Revolution Medicines, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $160,888 - $232,323	9,100 New	9,100 $216,000
Q2 2022 Aug 12, 2022	BUY	$14.54 - $27.17 $7,270 - $13,585	500 Added 3.11%	16,600 $324,000
Q1 2022 May 13, 2022	SELL	$17.31 - $26.4 $3,375 - $5,148	-195 Reduced 1.2%	16,100 $411,000
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $396,783 - $549,141	16,295 New	16,295 $410,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.